Category Specific RSS

News

Shift towards renewable energy drives Saudi Arabia floating solar market expansion

Saudi Arabia Onshore Floating Solar Market is rising due to increasing focus on renewable energy sources to diversify the energy…

2 years ago

Cleo’s ovarian cancer blood test proves more effective than CA125 clinical benchmark and ultrasound

A benchmarking study comparing ovarian cancer diagnostics company Cleo Diagnostics (ASX: COV)’s blood test against ultrasound has been published in…

2 years ago

Straker introduces AI Cloud and Verify services amid dwindling revenue and lowered sales

In FY24, AI-driven language and content services provider Straker (ASX: STG) faced market conditions tougher than initially expected, with lower…

2 years ago

AD1 secured contract extension with NSW Government for recruitment tech

The NSW Government has remained loyal to HR tech company AD1 Holdings (ASX: AD1) by ending their contract for 2-years…

2 years ago

From pain to gain: EPO grants PainChek patent in 20 European nations

Medical device company PainChek (ASX: PCK), developer of a smartphone-based pain assessment and monitoring application, has been granted a patent…

2 years ago

Bailador invests $20m in digital healthcare platform Updoc amid growing telehealth adoption

COVID-19 was a turning point for the telehealth industry. In Australia, between 2020 and 2022, more than 100 million telehealth…

2 years ago

Geopolitical tensions and the quest for military superiority motivate nations to invest in hypersonic weapons

According to TechSci Research report, “Hypersonic Weapons Market – Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2028”, the Global…

2 years ago

EMVision analysis confirms hyperacute and acute ischaemia stroke detection capabilities

Ischaemia is a condition in which the blood supply to any part of the body is so severely restricted that…

2 years ago

Genetic Signatures halts development of US respiratory product due to competition

Global molecular diagnostics company Genetic Signatures (ASX: GSS) has decided to halt the development of its EasyScreen Essentials Respiratory Detection…

2 years ago

PYC Therapeutics receives Orphan Drug Designation for ADOA treatment

PYC Therapeutics (ASX: PYC), a clinical-stage biotechnology company, has achieved a significant milestone with the U.S. Food and Drug Administration…

2 years ago